Maze Therapeutics Appoints Drug Development Expert Richard Scheller, Ph.D., to its Board of Directors
Posted by amanda punzalan under Press (No Respond)
SAN FRANCISCO, July 9, 2019 – Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Richard Scheller, Ph.D. has joined the company’s board of directors. We are thrilled to welcome Richard to our board…